In a recent survey, 89% of clinical adjudication users agreed clinical adjudication provides value to clinical trials. Why? Because using unbiased experts to evaluate a drug or device against predetermined criteria helps determine patient safety and clinical efficacy. Join two Clario experts for a discussion of these and other survey results to understand how they could impact your studies.
In the webinar, we will discuss:
Watch now to learn what to look for in a trusted adjudication partner for your next study.